Deutsche Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Deutsche Bank's SLXP Position: Q2 2015 in Review
Deutsche Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 68,753 shares — an estimated $11.9M sold.
Deutsche Bank first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $43.1M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- Deutsche Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
- Deutsche Bank sold 68,753 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $11.9M.
- Deutsche Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
- Deutsche Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $43.1M in Q4 2014.
- 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.
Based on Deutsche Bank's 13F filing for Q2 2015, filed 12 Aug 2015.